Showing results (281-290 of 378) with videos related to

Sort By:
Pageof 38
Biorxiv : the Preprint Server for Biology|February 27, 2026
SMARCAL1 is a candidate therapeutic target for ALT-positive tumorsAngelo Taglialatela, Jina Lee, Benura Azeroglu, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomasYaniv Kazansky, Helen S Mueller, Daniel Cameron, et al.
Blood|February 27, 2014
Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myelomaYu-Tzu Tai, Patrick A Mayes, Chirag Acharya, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcomaSarah Tannenbaum-Dvir, Julia L Glade Bender, Alanna J Church, et al.
Molecular Cancer Therapeutics|June 17, 2017
Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt LymphomaLisa Giulino-Roth, Herman J van Besien, Tanner Dalton, et al.
Nature Communications|March 26, 2014
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemiaBrenton G Mar, Lars B Bullinger, Kathleen M McLean, et al.
Cancer Cell|February 15, 2014
SYK is a critical regulator of FLT3 in acute myeloid leukemiaAlexandre Puissant, Nina Fenouille, Gabriela Alexe, et al.
The Journal of Clinical Investigation|August 12, 2025
Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomasYaniv Kazansky, Helen S Mueller, Daniel Cameron, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2014
An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinomaMaria Giuseppina Baratta, Anna C Schinzel, Yaara Zwang, et al.
Frontiers in Pediatrics|January 10, 2018
Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University ExperienceLianna J Marks, Jennifer A Oberg, Danielle Pendrick, et al.
Pageof 38